 | • レポートコード：QAF27805 • 出版社/出版日：QYResearch / 2021年4月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のニューカッスル病ワクチン市場について種類別（生ワクチン、不活化ワクチン）、用途別（鶏、アヒル＆ガチョウ、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ニューカッスル病ワクチン市場の概要 ・世界の主要地域別ニューカッスル病ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のニューカッスル病ワクチン市場規模2016-2021：種類別（生ワクチン、不活化ワクチン） ・世界のニューカッスル病ワクチン市場予測2012-2027：種類別（生ワクチン、不活化ワクチン） ・世界のニューカッスル病ワクチン市場規模2016-2021：用途別（鶏、アヒル＆ガチョウ、その他） ・世界のニューカッスル病ワクチン市場予測2012-2027：用途別（鶏、アヒル＆ガチョウ、その他） ・ニューカッスル病ワクチンのアメリカ市場規模と予測2016-2021 ・ニューカッスル病ワクチンのヨーロッパ市場規模と予測2016-2021 ・ニューカッスル病ワクチンの中国市場規模と予測2016-2021 ・ニューカッスル病ワクチンの日本市場規模と予測2016-2021 ・ニューカッスル病ワクチンの東南アジア市場規模と予測2016-2021 ・ニューカッスル病ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merial、CEVA、QYH Biotech、Ringpu Biology、Yebio、Harbin Veterinary Research Institute、Merck Animal Health、DHN、Zoetis、ChengDu Tecbond、Elanco (Lohmann)、FATRO、CAVAC、Vaksindo） ・ニューカッスル病ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ニューカッスル病ワクチンの市場動向・機会・課題 ・調査の結論 |
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.
Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.
Market Analysis and Insights: Global Newcastle Disease Vaccine Market
The global Newcastle Disease Vaccine market was valued at US$ 318.7 in 2020 and will reach US$ 391.7 million by the end of 2027, growing at a CAGR of 3.5% during 2022-2027.
Global Newcastle Disease Vaccine Scope and Market Size
The global Newcastle Disease Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Newcastle Disease Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Chicken
Duck & Goose
Other
The Newcastle Disease Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Newcastle Disease Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
1 Newcastle Disease Vaccine Market Overview
1.1 Newcastle Disease Vaccine Product Scope
1.2 Newcastle Disease Vaccine Segment by Type
1.2.1 Global Newcastle Disease Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine Segment by Application
1.3.1 Global Newcastle Disease Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Newcastle Disease Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Newcastle Disease Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Newcastle Disease Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Newcastle Disease Vaccine Price Trends (2016-2027)
2 Newcastle Disease Vaccine Estimates and Forecasts by Region
2.1 Global Newcastle Disease Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Newcastle Disease Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Newcastle Disease Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Newcastle Disease Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Newcastle Disease Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Newcastle Disease Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Newcastle Disease Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Newcastle Disease Vaccine Estimates and Projections (2016-2027)
2.4.3 China Newcastle Disease Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Newcastle Disease Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Newcastle Disease Vaccine Estimates and Projections (2016-2027)
2.4.6 India Newcastle Disease Vaccine Estimates and Projections (2016-2027)
3 Global Newcastle Disease Vaccine Competition Landscape by Players
3.1 Global Top Newcastle Disease Vaccine Players by Sales (2016-2021)
3.2 Global Top Newcastle Disease Vaccine Players by Revenue (2016-2021)
3.3 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2020)
3.4 Global Newcastle Disease Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Newcastle Disease Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Newcastle Disease Vaccine Market Size by Type
4.1 Global Newcastle Disease Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Newcastle Disease Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Newcastle Disease Vaccine Price by Type (2016-2021)
4.2 Global Newcastle Disease Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Newcastle Disease Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Newcastle Disease Vaccine Price Forecast by Type (2022-2027)
5 Global Newcastle Disease Vaccine Market Size by Application
5.1 Global Newcastle Disease Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Newcastle Disease Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Newcastle Disease Vaccine Price by Application (2016-2021)
5.2 Global Newcastle Disease Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Newcastle Disease Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Newcastle Disease Vaccine Price Forecast by Application (2022-2027)
6 North America Newcastle Disease Vaccine Market Facts & Figures
6.1 North America Newcastle Disease Vaccine Sales by Company
6.1.1 North America Newcastle Disease Vaccine Sales by Company (2016-2021)
6.1.2 North America Newcastle Disease Vaccine Revenue by Company (2016-2021)
6.2 North America Newcastle Disease Vaccine Sales Breakdown by Type
6.2.1 North America Newcastle Disease Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Newcastle Disease Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Newcastle Disease Vaccine Sales Breakdown by Application
6.3.1 North America Newcastle Disease Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Newcastle Disease Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Newcastle Disease Vaccine Market Facts & Figures
7.1 Europe Newcastle Disease Vaccine Sales by Company
7.1.1 Europe Newcastle Disease Vaccine Sales by Company (2016-2021)
7.1.2 Europe Newcastle Disease Vaccine Revenue by Company (2016-2021)
7.2 Europe Newcastle Disease Vaccine Sales Breakdown by Type
7.2.1 Europe Newcastle Disease Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Newcastle Disease Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Newcastle Disease Vaccine Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Newcastle Disease Vaccine Market Facts & Figures
8.1 China Newcastle Disease Vaccine Sales by Company
8.1.1 China Newcastle Disease Vaccine Sales by Company (2016-2021)
8.1.2 China Newcastle Disease Vaccine Revenue by Company (2016-2021)
8.2 China Newcastle Disease Vaccine Sales Breakdown by Type
8.2.1 China Newcastle Disease Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Newcastle Disease Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Newcastle Disease Vaccine Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Newcastle Disease Vaccine Market Facts & Figures
9.1 Japan Newcastle Disease Vaccine Sales by Company
9.1.1 Japan Newcastle Disease Vaccine Sales by Company (2016-2021)
9.1.2 Japan Newcastle Disease Vaccine Revenue by Company (2016-2021)
9.2 Japan Newcastle Disease Vaccine Sales Breakdown by Type
9.2.1 Japan Newcastle Disease Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Newcastle Disease Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Newcastle Disease Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Newcastle Disease Vaccine Market Facts & Figures
10.1 Southeast Asia Newcastle Disease Vaccine Sales by Company
10.1.1 Southeast Asia Newcastle Disease Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Newcastle Disease Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Newcastle Disease Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Newcastle Disease Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Newcastle Disease Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Newcastle Disease Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Newcastle Disease Vaccine Market Facts & Figures
11.1 India Newcastle Disease Vaccine Sales by Company
11.1.1 India Newcastle Disease Vaccine Sales by Company (2016-2021)
11.1.2 India Newcastle Disease Vaccine Revenue by Company (2016-2021)
11.2 India Newcastle Disease Vaccine Sales Breakdown by Type
11.2.1 India Newcastle Disease Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Newcastle Disease Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Newcastle Disease Vaccine Sales Breakdown by Application
11.3.1 India Newcastle Disease Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Newcastle Disease Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Newcastle Disease Vaccine Business
12.1 Merial
12.1.1 Merial Corporation Information
12.1.2 Merial Business Overview
12.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merial Newcastle Disease Vaccine Products Offered
12.1.5 Merial Recent Development
12.2 CEVA
12.2.1 CEVA Corporation Information
12.2.2 CEVA Business Overview
12.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CEVA Newcastle Disease Vaccine Products Offered
12.2.5 CEVA Recent Development
12.3 QYH Biotech
12.3.1 QYH Biotech Corporation Information
12.3.2 QYH Biotech Business Overview
12.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 QYH Biotech Newcastle Disease Vaccine Products Offered
12.3.5 QYH Biotech Recent Development
12.4 Ringpu Biology
12.4.1 Ringpu Biology Corporation Information
12.4.2 Ringpu Biology Business Overview
12.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ringpu Biology Newcastle Disease Vaccine Products Offered
12.4.5 Ringpu Biology Recent Development
12.5 Yebio
12.5.1 Yebio Corporation Information
12.5.2 Yebio Business Overview
12.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Yebio Newcastle Disease Vaccine Products Offered
12.5.5 Yebio Recent Development
12.6 Harbin Veterinary Research Institute
12.6.1 Harbin Veterinary Research Institute Corporation Information
12.6.2 Harbin Veterinary Research Institute Business Overview
12.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Products Offered
12.6.5 Harbin Veterinary Research Institute Recent Development
12.7 Merck Animal Health
12.7.1 Merck Animal Health Corporation Information
12.7.2 Merck Animal Health Business Overview
12.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Animal Health Newcastle Disease Vaccine Products Offered
12.7.5 Merck Animal Health Recent Development
12.8 DHN
12.8.1 DHN Corporation Information
12.8.2 DHN Business Overview
12.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 DHN Newcastle Disease Vaccine Products Offered
12.8.5 DHN Recent Development
12.9 Zoetis
12.9.1 Zoetis Corporation Information
12.9.2 Zoetis Business Overview
12.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zoetis Newcastle Disease Vaccine Products Offered
12.9.5 Zoetis Recent Development
12.10 ChengDu Tecbond
12.10.1 ChengDu Tecbond Corporation Information
12.10.2 ChengDu Tecbond Business Overview
12.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 ChengDu Tecbond Newcastle Disease Vaccine Products Offered
12.10.5 ChengDu Tecbond Recent Development
12.11 Elanco (Lohmann)
12.11.1 Elanco (Lohmann) Corporation Information
12.11.2 Elanco (Lohmann) Business Overview
12.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Products Offered
12.11.5 Elanco (Lohmann) Recent Development
12.12 FATRO
12.12.1 FATRO Corporation Information
12.12.2 FATRO Business Overview
12.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 FATRO Newcastle Disease Vaccine Products Offered
12.12.5 FATRO Recent Development
12.13 CAVAC
12.13.1 CAVAC Corporation Information
12.13.2 CAVAC Business Overview
12.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 CAVAC Newcastle Disease Vaccine Products Offered
12.13.5 CAVAC Recent Development
12.14 Vaksindo
12.14.1 Vaksindo Corporation Information
12.14.2 Vaksindo Business Overview
12.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Vaksindo Newcastle Disease Vaccine Products Offered
12.14.5 Vaksindo Recent Development
13 Newcastle Disease Vaccine Manufacturing Cost Analysis
13.1 Newcastle Disease Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Newcastle Disease Vaccine
13.4 Newcastle Disease Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Newcastle Disease Vaccine Distributors List
14.3 Newcastle Disease Vaccine Customers
15 Market Dynamics
15.1 Newcastle Disease Vaccine Market Trends
15.2 Newcastle Disease Vaccine Drivers
15.3 Newcastle Disease Vaccine Market Challenges
15.4 Newcastle Disease Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Newcastle Disease Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Newcastle Disease Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Newcastle Disease Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Newcastle Disease Vaccine Sales (M Doses) by Region (2016-2021)
Table 5. Global Newcastle Disease Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Newcastle Disease Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Newcastle Disease Vaccine Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Newcastle Disease Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Newcastle Disease Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Newcastle Disease Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Newcastle Disease Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Newcastle Disease Vaccine Sales Share by Company (2016-2021)
Table 14. Global Newcastle Disease Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Newcastle Disease Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Newcastle Disease Vaccine as of 2020)
Table 17. Global Newcastle Disease Vaccine Average Price (USD/K Doses) of Key Company (2016-2021)
Table 18. Manufacturers Newcastle Disease Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Newcastle Disease Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2016-2021)
Table 22. Global Newcastle Disease Vaccine Sales Share by Type (2016-2021)
Table 23. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2016-2021)
Table 25. Global Newcastle Disease Vaccine Sales Share by Type (2022-2027)
Table 26. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Newcastle Disease Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2022-2027)
Table 29. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2016-2021)
Table 30. Global Newcastle Disease Vaccine Sales Share by Application (2016-2021)
Table 31. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2016-2021)
Table 33. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2022-2027)
Table 34. Global Newcastle Disease Vaccine Sales Share by Application (2022-2027)
Table 35. Global Newcastle Disease Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Newcastle Disease Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2022-2027)
Table 38. North America Newcastle Disease Vaccine Sales (M Doses) by Company (2016-2021)
Table 39. North America Newcastle Disease Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Newcastle Disease Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Newcastle Disease Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 43. North America Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Newcastle Disease Vaccine Sales by Type (2022-2027) & (M Doses)
Table 45. North America Newcastle Disease Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 47. North America Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Newcastle Disease Vaccine Sales by Application (2022-2027) & (M Doses)
Table 49. North America Newcastle Disease Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Newcastle Disease Vaccine Sales (M Doses) by Company (2016-2021)
Table 51. Europe Newcastle Disease Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Newcastle Disease Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Newcastle Disease Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Newcastle Disease Vaccine Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Newcastle Disease Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Newcastle Disease Vaccine Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Newcastle Disease Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Newcastle Disease Vaccine Sales (M Doses) by Company (2016-2021)
Table 63. China Newcastle Disease Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Newcastle Disease Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Newcastle Disease Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 67. China Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Newcastle Disease Vaccine Sales by Type (2022-2027) & (M Doses)
Table 69. China Newcastle Disease Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 71. China Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Newcastle Disease Vaccine Sales by Application (2022-2027) & (M Doses)
Table 73. China Newcastle Disease Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Newcastle Disease Vaccine Sales (M Doses) by Company (2016-2021)
Table 75. Japan Newcastle Disease Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Newcastle Disease Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Newcastle Disease Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Newcastle Disease Vaccine Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Newcastle Disease Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Newcastle Disease Vaccine Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Newcastle Disease Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Newcastle Disease Vaccine Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Newcastle Disease Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Newcastle Disease Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Newcastle Disease Vaccine Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Newcastle Disease Vaccine Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Newcastle Disease Vaccine Sales (M Doses) by Company (2016-2021)
Table 99. India Newcastle Disease Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Newcastle Disease Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Newcastle Disease Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Newcastle Disease Vaccine Sales by Type (2016-2021) & (M Doses)
Table 103. India Newcastle Disease Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Newcastle Disease Vaccine Sales by Type (2022-2027) & (M Doses)
Table 105. India Newcastle Disease Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Newcastle Disease Vaccine Sales by Application (2016-2021) & (M Doses)
Table 107. India Newcastle Disease Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Newcastle Disease Vaccine Sales by Application (2022-2027) & (M Doses)
Table 109. India Newcastle Disease Vaccine Sales Market Share by Application (2022-2027)
Table 110. Merial Corporation Information
Table 111. Merial Description and Business Overview
Table 112. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 113. Merial Newcastle Disease Vaccine Product
Table 114. Merial Recent Development
Table 115. CEVA Corporation Information
Table 116. CEVA Description and Business Overview
Table 117. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 118. CEVA Newcastle Disease Vaccine Product
Table 119. CEVA Recent Development
Table 120. QYH Biotech Corporation Information
Table 121. QYH Biotech Description and Business Overview
Table 122. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 123. QYH Biotech Newcastle Disease Vaccine Product
Table 124. QYH Biotech Recent Development
Table 125. Ringpu Biology Corporation Information
Table 126. Ringpu Biology Description and Business Overview
Table 127. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 128. Ringpu Biology Newcastle Disease Vaccine Product
Table 129. Ringpu Biology Recent Development
Table 130. Yebio Corporation Information
Table 131. Yebio Description and Business Overview
Table 132. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 133. Yebio Newcastle Disease Vaccine Product
Table 134. Yebio Recent Development
Table 135. Harbin Veterinary Research Institute Corporation Information
Table 136. Harbin Veterinary Research Institute Description and Business Overview
Table 137. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 138. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 139. Harbin Veterinary Research Institute Recent Development
Table 140. Merck Animal Health Corporation Information
Table 141. Merck Animal Health Description and Business Overview
Table 142. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 143. Merck Animal Health Newcastle Disease Vaccine Product
Table 144. Merck Animal Health Recent Development
Table 145. DHN Corporation Information
Table 146. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 147. DHN Description and Business Overview
Table 148. DHN Newcastle Disease Vaccine Product
Table 149. DHN Recent Development
Table 150. Zoetis Corporation Information
Table 151. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 152. Zoetis Description and Business Overview
Table 153. Zoetis Newcastle Disease Vaccine Product
Table 154. Zoetis Recent Development
Table 155. ChengDu Tecbond Corporation Information
Table 156. ChengDu Tecbond Description and Business Overview
Table 157. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 158. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 159. ChengDu Tecbond Recent Development
Table 160. Elanco (Lohmann) Corporation Information
Table 161. Elanco (Lohmann) Description and Business Overview
Table 162. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 163. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 164. Elanco (Lohmann) Recent Development
Table 165. FATRO Corporation Information
Table 166. FATRO Description and Business Overview
Table 167. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 168. FATRO Newcastle Disease Vaccine Product
Table 169. FATRO Recent Development
Table 170. CAVAC Corporation Information
Table 171. CAVAC Description and Business Overview
Table 172. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 173. CAVAC Newcastle Disease Vaccine Product
Table 174. CAVAC Recent Development
Table 175. Vaksindo Corporation Information
Table 176. Vaksindo Description and Business Overview
Table 177. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 178. Vaksindo Newcastle Disease Vaccine Product
Table 179. Vaksindo Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Newcastle Disease Vaccine Distributors List
Table 183. Newcastle Disease Vaccine Customers List
Table 184. Newcastle Disease Vaccine Market Trends
Table 185. Newcastle Disease Vaccine Market Drivers
Table 186. Newcastle Disease Vaccine Market Challenges
Table 187. Newcastle Disease Vaccine Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Newcastle Disease Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Chicken Examples
Figure 7. Duck & Goose Examples
Figure 8. Other Examples
Figure 9. Global Newcastle Disease Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Newcastle Disease Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Newcastle Disease Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 12. Global Newcastle Disease Vaccine Price Trends Growth Rate (2016-2027) (USD/K Doses)
Figure 13. Global Newcastle Disease Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Newcastle Disease Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Newcastle Disease Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 17. Europe Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Newcastle Disease Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Newcastle Disease Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Newcastle Disease Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Newcastle Disease Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Newcastle Disease Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Newcastle Disease Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Newcastle Disease Vaccine Players Market Share by Revenue in Newcastle Disease Vaccine: 2016 & 2020
Figure 28. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Newcastle Disease Vaccine Revenue Share by Type (2016-2021)
Figure 30. Global Newcastle Disease Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Newcastle Disease Vaccine Revenue Share by Application (2016-2021)
Figure 32. Global Newcastle Disease Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 34. North America Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 35. Europe Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 36. Europe Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 37. China Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 38. China Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 39. Japan Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 40. Japan Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 41. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 42. Southeast Asia Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 43. India Newcastle Disease Vaccine Sales Market Share by Type in 2020
Figure 44. India Newcastle Disease Vaccine Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Newcastle Disease Vaccine
Figure 47. Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure 48. Newcastle Disease Vaccine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の水産養殖用ワクチン市場規模・現状・予測（2021年-2027年） It is a biological preparation that improves immunity to a particular disease work on aquaculture. Market Analysis and Insights: Global Aquaculture Vaccine Market The global Aquaculture Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% du…- インフルエンザワクチンのグローバル市場2021 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
- 世界のmRNAワクチン＆治療薬市場規模・現状・予測（2021年-2027年） mRNA vaccine is the drugs prepared using advanced technologies using mRNA as the genetic material. mRNA vaccines are a more efficient alternative owing to their enhanced immunogenicity, higher potency, rapid development, relatively cheaper and safer over conventional vaccines. Market Analysis and In…
- 魚類ワクチンのグローバル市場2021 Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed an…
- 動物用ワクチンアジュバントのグローバル市場2021 An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vacci…